[
 {
  "title": "Low-Carbohydrate Diets and Cholesterol Levels",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "Discusses the experience with low-carbohydrate diets and the hypothesis that cholesterol levels are influenced by energy metabolism.",
  "content_length": 132,
  "content_tokens": 22,
  "embedding": []
 },
 {
  "title": "Lipid Energy Model",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "Discusses the lipid energy model.",
  "content_length": 33,
  "content_tokens": 7,
  "embedding": []
 },
 {
  "title": "Inversion Pattern Experiments",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "Discusses inversion pattern experiments.",
  "content_length": 40,
  "content_tokens": 7,
  "embedding": []
 },
 {
  "title": "Standard Blood Panels and Sterol Panels",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "Discusses standard blood panels, sterol panels, and what moves the needle when it comes to particle numbers.",
  "content_length": 108,
  "content_tokens": 22,
  "embedding": []
 },
 {
  "title": "Hyper-Responders",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "Discusses hyper-responders.",
  "content_length": 27,
  "content_tokens": 7,
  "embedding": []
 },
 {
  "title": "Lipoprotein Transport",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "Discusses lipoprotein transport.",
  "content_length": 32,
  "content_tokens": 7,
  "embedding": []
 },
 {
  "title": "Lean Mass Hyper-Responder Phenotype",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "Discusses the lean mass hyper-responder phenotype.",
  "content_length": 50,
  "content_tokens": 11,
  "embedding": []
 },
 {
  "title": "Progression of Atherosclerosis, CAC, and CIMT",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "Discusses the progression of atherosclerosis, CAC, and CIMT.",
  "content_length": 60,
  "content_tokens": 17,
  "embedding": []
 },
 {
  "title": "Testing for Oxidized LDL",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "Discusses testing for oxidized LDL.",
  "content_length": 35,
  "content_tokens": 8,
  "embedding": []
 },
 {
  "title": "All-Cause Mortality and Clinical Endpoints",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "Discusses all-cause mortality and clinical endpoints.",
  "content_length": 53,
  "content_tokens": 11,
  "embedding": []
 },
 {
  "title": "LDL as Causal",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "Discusses what does 'LDL as causal' mean.",
  "content_length": 41,
  "content_tokens": 12,
  "embedding": []
 },
 {
  "title": "Low Carb Cholesterol Challenge and Drug & Genetic Study Qualifications",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "Discusses the low carb cholesterol challenge and drug & genetic study qualifications.",
  "content_length": 85,
  "content_tokens": 14,
  "embedding": []
 },
 {
  "title": "Case Studies and Self-Experiment",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "Discusses if all other markers are in a healthy range, but LDL-P is high, is the patient at risk? A couple of case studies, and a self-experiment.",
  "content_length": 146,
  "content_tokens": 38,
  "embedding": []
 },
 {
  "title": "Exercise and Ketosis Experiment",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "Discusses the three-day exercise and ketosis experiment.",
  "content_length": 56,
  "content_tokens": 12,
  "embedding": []
 },
 {
  "title": "Remnant Lipoproteins",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "Discusses what are remnant lipoproteins.",
  "content_length": 40,
  "content_tokens": 10,
  "embedding": []
 },
 {
  "title": "Higher LDL Particle Numbers in Lean Mass Hyper-Responders",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "Discusses what might cause lean mass hyper-responders to have higher LDL particle numbers.",
  "content_length": 90,
  "content_tokens": 18,
  "embedding": []
 },
 {
  "title": "Mass Balance and Cholesterol Flux",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "Discusses mass balance and cholesterol flux.",
  "content_length": 44,
  "content_tokens": 8,
  "embedding": []
 },
 {
  "title": "Higher Degree of Cholesterol in Lean Mass Hyper-Responder Phenotype",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "Discusses if a higher degree of cholesterol can explain the lean mass hyper-responder phenotype.",
  "content_length": 96,
  "content_tokens": 19,
  "embedding": []
 },
 {
  "title": "Substituting Saturated Fats with Monounsaturated Fats",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "Discusses if substituting saturated fats with monounsaturated fats lower LDL-P and LDL-C.",
  "content_length": 89,
  "content_tokens": 22,
  "embedding": []
 },
 {
  "title": "Carb-Swap Experiments",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "Discusses the carb-swap experiments.",
  "content_length": 36,
  "content_tokens": 9,
  "embedding": []
 },
 {
  "title": "Carotid Intima-Media Thickness Tests",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "Discusses the carotid intima-media thickness tests.",
  "content_length": 51,
  "content_tokens": 13,
  "embedding": []
 },
 {
  "title": "Studies on High HDL-C and Low TG alongside Low and High LDL-C",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "Discusses looking for studies that stratify for high HDL-C and low TG alongside low and high LDL-C.",
  "content_length": 99,
  "content_tokens": 24,
  "embedding": []
 },
 {
  "title": "Optimizing Brain Health",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "Alzheimer's disease risk factors, APOE, prevention strategies, and more.",
  "content_length": 72,
  "content_tokens": 17,
  "embedding": []
 },
 {
  "title": "Training Principles for Longevity",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "Training principles for longevity.",
  "content_length": 34,
  "content_tokens": 5,
  "embedding": []
 },
 {
  "title": "Preventing Cardiovascular Disease",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "The latest in diagnostic imaging, blood pressure, metabolic health, and more.",
  "content_length": 77,
  "content_tokens": 15,
  "embedding": []
 },
 {
  "title": "Pros and Cons of GLP-1 Weight Loss Drugs and Metformin",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "Pros and cons of GLP-1 weight loss drugs and metformin as a geroprotective agent.",
  "content_length": 81,
  "content_tokens": 23,
  "embedding": []
 },
 {
  "title": "Cholesterol Levels and Energy Metabolism",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "Cholesterol levels are influenced by energy metabolism. Standard blood panels, sterol panels, and what moves the needle when it comes to particle numbers. Hyper-responders. Lipoprotein transport. The lean mass hyper-responder phenotype. The progression of atherosclerosis, CAC, and CIMT. Testing for oxidized LDL. All-cause mortality and clinical endpoints. What does “LDL as causal” mean? If all other markers are in a healthy range, but LDL-P is high, is the patient at risk? A couple of case studies, and a self-experiment. What are remnant lipoproteins? What might cause lean mass hyper-responders to have higher LDL particle numbers? Can a higher degree of cholesterol explain the lean mass hyper-responder phenotype? Does substituting saturated fats with monounsaturated fats lower LDL-P and LDL-C?",
  "content_length": 804,
  "content_tokens": 186,
  "embedding": []
 },
 {
  "title": "Dietary Fat and Cholesterol Levels",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "In April 2015, a software engineer went on a low-carb high-fat (LCHF) diet and felt better than ever. November 24, 2015: Total Cholesterol (TC): 329. He was averaging 224 gm fat/d for the 3-days prior to the test. He decreased the fat in his diet (still LC) to 83 gm fat/d. December 9, 2015: TC: 424. From this point, he started doing N=1 experiments. Started tracking food intake and blood tests (51 tests in 15 months). He can move his LDL-C and LDL-P count up and down without medication or supplements by finding what he believes to be the primary influencer: energy metabolism (especially fatty acid utilization for energy).",
  "content_length": 629,
  "content_tokens": 155,
  "embedding": []
 },
 {
  "title": "Standard Blood Panels and Particle Numbers",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "Peter reviews lipid values prior to going LCHF. TC (approximately): 186. LDL-C:131. HDL-C 40. TG: 80. TG:HDL-C ratio: 2. Unfortunately, labs for LDL-P or apoB were not taken, and acknowledges this is important to understand more about what’s happening.",
  "content_length": 252,
  "content_tokens": 72,
  "embedding": []
 },
 {
  "title": "Hyper-Responders and Lipoprotein Transport",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "Hyper-responders are people who see their TC, LDL-C, and LDL-P go way up on a LCHF diet. It’s essential that people get a sterol panel in addition to an advanced lipid panel. LDL-P and ApoB are affected by four things: The amount of cholesterol you synthesize, the amount of cholesterol (or sterol) that you reabsorb, the amount of triglycerides (TGs) you have to carry around, and your clearance of the particles.",
  "content_length": 414,
  "content_tokens": 107,
  "embedding": []
 },
 {
  "title": "Lean Mass Hyper-Responder Phenotype",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "Lean mass hyper-responders (LMHRs), people who are athletic, lean, and very low carb, see very high levels of LDL-C and LDL-P, and very high levels of HDL-C, and low levels of triglycerides. They may show a very high rate, proportionally, of VLDL secretion. They are trafficking a lot more, for their energy, triglycerides in VLDL particles, and therefore have succeeding LDL particles, which would explain why their LDL-C and LDL-P would be higher.",
  "content_length": 449,
  "content_tokens": 111,
  "embedding": []
 },
 {
  "title": "Progression of Atherosclerosis, CAC, and CIMT",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "CIMT: Carotid Intima-Media Thickness test. CAC: Coronary Artery Calcium test. These are both tests that are used to try to gauge advanced disease. The arteries have an endothelial lining, a very thin type of cell, forming an interface between circulating blood or lymph in the lumen and the rest of the vessel wall. Lipoproteins get in there and out of there all the time. The problem occurs when proteoglycans bind to the apoB on LDLs, it gets retained, all of a sudden now you have something that’s where it’s not supposed to be. It’s obviously in a high oxygen environment, so it’s going to undergo a chemical reaction called oxidation. It’s that oxidative reaction that then kicks off an inflammatory response in the endothelium.",
  "content_length": 733,
  "content_tokens": 180,
  "embedding": []
 },
 {
  "title": "Atherosclerosis Progression and Oxidized LDL",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "A lab test can get an estimation of the oxidative burden, the OxLDL assay. It turns out some very small percentage of those LDLs, once they are oxidized, escape back into the circulation. It’s important to understand that when you get a blood test, that’s not telling you what’s happening in your artery. It’s giving you probabilities of things that are largely stochastically governed, that are going on in your artery. And the oxLDL is no exception.",
  "content_length": 451,
  "content_tokens": 107,
  "embedding": []
 },
 {
  "title": "LDL-P and Vitamin E",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "LDL particles, specifically apoB100 at the LDL stage, have alpha-tocopherol. Part of the purpose of an LDL particle is to actually provide that as a means to battle reactive oxygen species. There’s the potential of the phospholipid shell of LDL particles to become oxidized. If you get oxidized phospholipids, that also can bring about the role Lp(a), that can cleave off the oxidized phospholipids.",
  "content_length": 399,
  "content_tokens": 99,
  "embedding": []
 },
 {
  "title": "All-cause Mortality and Clinical Endpoints",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "Most short-term studies don’t have the statistical ability to detect all-cause mortality (ACM), because of the manner in which they’re powered. It’s hard enough to detect cardiac mortality in a study. The concern is, if you are less likely to die of heart disease, are you more likely to die of something else? It’s not uncommon in cardiovascular studies to see a reduction in coronary mortality with no change in all-cause mortality, or a non-statistical change.",
  "content_length": 463,
  "content_tokens": 107,
  "embedding": []
 },
 {
  "title": "LDL as Causal",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "Peter believes that the lower the LDL, the lower the risk of cardiovascular disease, all other things equal. Because LDL is necessary, but not sufficient for atherosclerosis. Peter argues that cardiovascular disease is primarily driven by three things: Lipoproteins (Lp[a], LDL-P, small LDL-P, VLDL remnant), Inflammation (nonspecific: fibrinogen, hs-CRP; specific: oxLDL, Lp-PLA2, oxPL), Endothelial dysfunction (insulin, Hcy, ADMA, and SDMA).",
  "content_length": 444,
  "content_tokens": 123,
  "embedding": []
 },
 {
  "title": "Dave’s Low Carb Cholesterol Challenge and Drug & Genetic Study Qualifications",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "Dave has a pinned Tweet, requesting people submit studies that can demonstrate that people with high HDL-C, low TGs, and high LDL-C. There are two qualifications: no drug studies and no genetic studies. Peter has an issue with the qualifications: why would you limit yourself from genetic studies, which are themselves the basis for Mendelian Randomization?",
  "content_length": 357,
  "content_tokens": 73,
  "embedding": []
 },
 {
  "title": "Case Studies and Self-experiment",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "Peter provides a patient’s case as an example of a hyper-response to a LCHF diet. This is a male patient who’s been on a low carb diet for a couple of years, and is achieving amazing success with it. His glucose disposal is excellent, his insulin levels are very low, his c-reactive protein is 0.3. However, his oxLDL is the highest Peter has ever seen and the same is true of his LpPLA2. Even if this patient had a negative calcium score (which he did not), Peter would have still recommended lipid lowering therapy and/or modification of diet.",
  "content_length": 545,
  "content_tokens": 131,
  "embedding": []
 },
 {
  "title": "Receptor Mediated Endocytosis for Muscle Repair and Growth",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "There’s a greater overall gradient of receptor mediated endocytosis for muscle repair and growth with resistance training. If the hypothesis is true, LDL-C and LDL-P might change: more use of the product of LDL-P directly by the cells.",
  "content_length": 235,
  "content_tokens": 54,
  "embedding": []
 },
 {
  "title": "Risk Based on Lipoproteins Results",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "This patient is at risk based on his lipoproteins results, because this is one of the three legs of the stool: the burden of lipoprotein, the endothelial function or health, and the inflammatory response to it.",
  "content_length": 210,
  "content_tokens": 47,
  "embedding": []
 },
 {
  "title": "Hypertriglyceridemia and Hypercholesterolemia in Diabetic Ketoacidosis",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "Hypertriglyceridemia and hypercholesterolemia that gets corrected after treating diabetic ketoacidosis.",
  "content_length": 103,
  "content_tokens": 23,
  "embedding": []
 },
 {
  "title": "Exercise and Lipoprotein Response",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "Self-experiment with exercise and lipoprotein response: Resistance Training Experiment – Findings.",
  "content_length": 98,
  "content_tokens": 19,
  "embedding": []
 },
 {
  "title": "Three-Day Exercise and Ketosis Experiment",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "An experiment where extensive blood tests, three tests a day, for three days, doing different types of exercise. The tests are not commercially available: tested pre-workout, immediately post-workout, and four hours later, looking at LDL, VLDL, and HDL particles, both in terms of their cholesterol and triglyceride content.",
  "content_length": 324,
  "content_tokens": 69,
  "embedding": []
 },
 {
  "title": "Remnant Lipoproteins",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "There are different definitions of “remnants”. The poor-man’s version of remnant cholesterol is TG/5, which is the estimated VLDL-C. This is actually part of the Friedewald equation and how LDL-C is calculated on most standard panels.",
  "content_length": 234,
  "content_tokens": 60,
  "embedding": []
 },
 {
  "title": "Lean Mass Hyper-Responders and LDL Particle Numbers",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "What might cause lean mass hyper-responders to have higher LDL particle numbers? It is believed that lean mass hyper-responders are powered much more by triglycerides carried within VLDL particles, and therefore having more subsequent LDL particles.",
  "content_length": 249,
  "content_tokens": 48,
  "embedding": []
 },
 {
  "title": "Fat Flux",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "When running, there’s a state of negative fat flux (or fat efflux). The liver is the “energostat” of the body, a term borrowed from Mark Friedman. The job of chylomicrons is to deliver fat based energy.",
  "content_length": 202,
  "content_tokens": 56,
  "embedding": []
 },
 {
  "title": "Mass Balance and Cholesterol Flux",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "If an individual goes from an LDL-C of 100 mg/dL to 300 mg/dL, this increase of 200 mg/dL needs to be accounted for — he can: Make more cholesterol, and/or Clear less cholesterol, and/or Take cholesterol from an existing pool (e.g., cell membranes).",
  "content_length": 249,
  "content_tokens": 64,
  "embedding": []
 },
 {
  "title": "Keto-Fast-Keto Experiment",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "A week of a ketogenic diet, followed by a week of fasting, followed by a week of ketosis resulted in an increase in LDL-P after one week of ketosis. LDL-C went from 64 to 37 after the one-week fast. Under caloric deprivation, LDL goes down and under fat deprivation, LDL goes down.",
  "content_length": 281,
  "content_tokens": 68,
  "embedding": []
 },
 {
  "title": "Saturated Fats and LDL-P and LDL-C",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "In patients on a high-fat diet, the ones that go on to have a hyper-response, TGs go down, TC goes through the roof, and there’s a 2-3x+ greater output of synthetic biomarkers like desmosterol. This seems reversible, if you reduce saturated fat (SFA) to <25-30 g/day. LDL-P fell from >3,500 nmol/L to about 1,300 nmol/L (about 55th percentile), and CRP fell from 2.9 mg/L to <0.3 mg/L.",
  "content_length": 385,
  "content_tokens": 125,
  "embedding": []
 },
 {
  "title": "Carb-Swap Experiments",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "Carb-swap experiments, where carbohydrates were added to the diet to increase glycogen stores, resulted in less VLDL secretion, and therefore less LDL. There are very little glycogen stores on LCHF relative to a high-carb diet.",
  "content_length": 227,
  "content_tokens": 52,
  "embedding": []
 },
 {
  "title": "Carotid Intima-Media Thickness Tests",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "Carotid intima-media test (CIMT) every six months showed a regression on both the left and right side of the carotid arteries. From a cardiovascular standpoint, there is no single good reason to have high LDL.",
  "content_length": 209,
  "content_tokens": 49,
  "embedding": []
 },
 {
  "title": "High HDL-C and Low TG alongside Low and High LDL-C",
  "date": "October 8, 2018",
  "context": "Cholesterol",
  "people": "Peter Attia",
  "content": "Looking for any datasets that can demonstrate that people with high HDL-C, low TGs, and high LDL-C (and high LDL-P, if available) are at increased risk for CVD. Framingham Offspring study found the associated risk for people with LDL-C > 130, and with high HDL-C and low TG, their risk was the same as people with an LDL-C < 100.",
  "content_length": 329,
  "content_tokens": 85,
  "embedding": []
 }
]